Literature DB >> 9230439

A minK-HERG complex regulates the cardiac potassium current I(Kr).

T V McDonald1, Z Yu, Z Ming, E Palma, M B Meyers, K W Wang, S A Goldstein, G I Fishman.   

Abstract

MinK is a widely expressed protein of relative molecular mass approximately 15K that forms potassium channels by aggregation with other membrane proteins. MinK governs ion channel activation, regulation by second messengers, and the function and structure of the ion conduction pathway. Association of minK with a channel protein known as KvLQT1 produces a voltage-gated outward K+ current (I[sK]) resembling the slow cardiac repolarization current (I[Ks]). HERG, a human homologue of the ether-a-go-go gene of the fruitfly Drosophila melanogaster, encodes a protein that produces the rapidly activating cardiac delayed rectifier (I[Kr]). These two potassium currents, I(Ks) and I(Kr), provide the principal repolarizing currents in cardiac myocytes for the termination of action potentials. Although heterologously expressed HERG channels are largely indistinguishable from native cardiac I(Kr), a role for minK in this current is suggested by the diminished I(Kr) in an atrial tumour line subjected to minK antisense suppression. Here we show that HERG and minK form a stable complex, and that this heteromultimerization regulates I(Kr) activity. MinK, through the formation of heteromeric channel complexes, is thus central to the control of the heart rate and rhythm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230439     DOI: 10.1038/40882

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.

Authors:  A G Teschemacher; E P Seward; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium.

Authors:  J M Nerbonne
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes.

Authors:  H B Nuss; E Marbán; D C Johns
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity.

Authors:  Anna Kagan; Yonathan F Melman; Andrew Krumerman; Thomas V McDonald
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

5.  KCNE4 is an inhibitory subunit to the KCNQ1 channel.

Authors:  Morten Grunnet; Thomas Jespersen; Hanne Borger Rasmussen; Trine Ljungstrøm; Nanna K Jorgensen; Søren-Peter Olesen; Dan A Klaerke
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

6.  Differential regulation of the slow and rapid components of guinea-pig cardiac delayed rectifier K+ channels by hypoxia.

Authors:  Livia C Hool
Journal:  J Physiol       Date:  2003-11-21       Impact factor: 5.182

Review 7.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

8.  KCNE2 protein is more abundant in ventricles than in atria and can accelerate hERG protein degradation in a phosphorylation-dependent manner.

Authors:  Mei Zhang; Yuhong Wang; Min Jiang; Dimitar P Zankov; Sabeeha Chowdhury; Vigneshwar Kasirajan; Gea-Ny Tseng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

9.  PKA phosphorylation of HERG protein regulates the rate of channel synthesis.

Authors:  Jian Chen; Jakub Sroubek; Yamini Krishnan; Yan Li; Jinsong Bian; Thomas V McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

10.  The Polymorphic Analysis of the Human Potassium Channel KCNE Gene Family in Meniere's Disease-A Preliminary Study.

Authors:  Qingqing Dai; Dan Wang; Hong Zheng
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.